THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 52 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,649,584 | -70.4% | 17,713,600 | +2.8% | 1.01% | -65.3% |
Q2 2023 | $160,790,122 | +5.1% | 17,233,668 | 0.0% | 2.91% | -3.0% |
Q1 2023 | $153,034,972 | +78.3% | 17,233,668 | 0.0% | 3.00% | +82.9% |
Q4 2022 | $85,823,667 | -13.2% | 17,233,668 | +1.1% | 1.64% | -10.5% |
Q3 2022 | $98,842,000 | +4.9% | 17,041,668 | 0.0% | 1.84% | +7.4% |
Q2 2022 | $94,240,000 | -52.0% | 17,041,668 | 0.0% | 1.71% | -46.4% |
Q1 2022 | $196,490,000 | -8.0% | 17,041,668 | +1.2% | 3.19% | +16.1% |
Q4 2021 | $213,514,000 | – | 16,838,668 | – | 2.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Opportunity Management V, LLC | 959,275 | $5,564,000 | 16.70% |
Foresite Capital Management V, LLC | 3,335,346 | $19,345,000 | 14.87% |
Lynx1 Capital Management LP | 504,862 | $2,928,000 | 2.64% |
Orbimed Advisors | 17,041,668 | $98,842,000 | 1.84% |
Omega Fund Management, LLC | 711,479 | $4,127,000 | 1.51% |
Nextech Invest Ltd. | 611,310 | $3,546,000 | 1.14% |
Opaleye Management Inc. | 220,650 | $1,280,000 | 0.53% |
Boxer Capital, LLC | 892,057 | $5,174,000 | 0.29% |
DAFNA Capital Management LLC | 81,899 | $475,000 | 0.13% |
Rock Springs Capital Management LP | 437,329 | $2,537,000 | 0.07% |